These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21051675)

  • 61. Aripiprazole and depression in schizoaffective disorder.
    Errico JR; Yates WR
    Am J Psychiatry; 2005 Mar; 162(3):626-7. PubMed ID: 15741489
    [No Abstract]   [Full Text] [Related]  

  • 62. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
    da Rocha FF; Correa H
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1550-1. PubMed ID: 17692447
    [No Abstract]   [Full Text] [Related]  

  • 63. Remission of schizophrenia psychosis and strong reduction of obsessive-compulsive disorder after adding clozapine to aripiprazole.
    Peters B; de Haan L
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1576-7. PubMed ID: 19766686
    [No Abstract]   [Full Text] [Related]  

  • 64. Supersensitivity psychosis after tapering aripiprazole: a case report.
    Chang CC; Hsu WY; Chen SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):388-9. PubMed ID: 19166895
    [No Abstract]   [Full Text] [Related]  

  • 65. Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1157-8; author reply 1159. PubMed ID: 20381569
    [No Abstract]   [Full Text] [Related]  

  • 66. Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist.
    Burke MJ; Lincoln J
    Ann Clin Psychiatry; 2006; 18(2):129-30. PubMed ID: 16754419
    [No Abstract]   [Full Text] [Related]  

  • 67. Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.
    Trutia A; Bledowski J; Pandurangi A; Kahn DA
    J Psychiatr Pract; 2008 Nov; 14(6):398-402. PubMed ID: 19057242
    [No Abstract]   [Full Text] [Related]  

  • 68. Aripiprazole: striving towards euthymia with a novel mechanism of action.
    McIntyre RS
    J Affect Disord; 2011 Jan; 128 Suppl 1():S1-2. PubMed ID: 21220075
    [No Abstract]   [Full Text] [Related]  

  • 69. Delusional infestation responding to blonanserin.
    Bhatia MS; Rathi A; Jhanjee A
    J Neuropsychiatry Clin Neurosci; 2013; 25(4):E54. PubMed ID: 24247894
    [No Abstract]   [Full Text] [Related]  

  • 70. [Morgellons syndrome: a disease transmitted via the media].
    Misery L
    Ann Dermatol Venereol; 2013 Jan; 140(1):59-62. PubMed ID: 23328363
    [No Abstract]   [Full Text] [Related]  

  • 71. Treatment of Oral Mucosal Lesions Associated With Overlapping Psychodermatologic Disorders.
    Alfaris S; France K; Sollecito TP; Stoopler ET
    Compend Contin Educ Dent; 2018 Apr; 39(4):244-1246. PubMed ID: 29600872
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Formication, tactile hallucinations, delusional parasitosis, and Morgellons: Enough to make your skin crawl.
    Dowben JS; Kowalski PC; Keltner NL
    Perspect Psychiatr Care; 2017 Oct; 53(4):220-221. PubMed ID: 28960311
    [No Abstract]   [Full Text] [Related]  

  • 73. How to improve the interface between dermatology and psychiatry: a review and expert suggestion regarding the management of delusional patients.
    Starzyk T; Koo J
    Dermatol Online J; 2021 Oct; 27(10):. PubMed ID: 35130384
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Morgellons, a 'socially transmitted' disease].
    van der Bent SAS; Kemperman PM; Vulink NC; Hoekzema R
    Ned Tijdschr Geneeskd; 2019 Nov; 163():. PubMed ID: 31750635
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Morgellons disease as internet meme.
    Lustig A; Mackay S; Strauss J
    Psychosomatics; 2009; 50(1):90. PubMed ID: 19213978
    [No Abstract]   [Full Text] [Related]  

  • 76. Morgellons disease and delusions of parasitosis.
    Robles DT; Olson JM; Combs H; Romm S; Kirby P
    Am J Clin Dermatol; 2011 Feb; 12(1):1-6. PubMed ID: 21110523
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypnosis in the treatment of Morgellons disease: a case study.
    Gartner AM; Dolan SL; Stanford MS; Elkins GR
    Int J Clin Exp Hypn; 2011 Apr; 59(2):242-9. PubMed ID: 21390982
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Morgellons disease: more questions than answers.
    Stricker RB; Middelveen MJ
    Psychosomatics; 2012; 53(5):504-5; author reply 505-6. PubMed ID: 22959062
    [No Abstract]   [Full Text] [Related]  

  • 79. The first investigative science-based evidence of Morgellons psychogenesis.
    Roncati L; Gatti AM; Pusiol T; Piscioli F; Barbolini G; Maiorana A
    Ultrastruct Pathol; 2016; 40(5):249-53. PubMed ID: 27269255
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is Morgellons an organic disease? structural and functional abnormalities implicated in the pathophysiology of delusional infestation.
    Chan S; Xiao A; Patel S; Nakamura M; Koo J
    Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.